The effect of Ginkgo biloba in isolated ischemic/reperfused rat heart: A link between vitamin E preservation and prostaglandin biosynthesis

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 3, 2004, Pages 356-362

  Kusmic, Claudia ^a,c   Basta, Giuseppina ^a   Lazzerini, Guido ^a   Vesentini, Nicoletta ^a   Barsacchi, Renata ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c CNR   (Italy)

Author keywords

Antioxidants; EGb 761; Ischemia; Rat heart; Reperfusion; Transcription factor NF B

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; GINKGO BILOBA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOLIPASE A2; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GINKGO BILOBA; HEART MUSCLE ISCHEMIA; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CELL NUCLEUS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FREEZE DRYING; GINKGO BILOBA; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NF-KAPPA B; OXIDATIVE STRESS; PERFUSION; PLANT EXTRACTS; RATS; RATS, WISTAR; TRANSCRIPTION FACTORS; VITAMIN E;

EID: 4344662675     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000137164.99487.42     Document Type: Article

References (40)

1. Kleijenen J, Knipschild P. Ginkgo biloba. Lancet. 1992;340:1136-1139.
2. 2+-loaded brain neurons. Brain Res. 1994;635:125-129.
3. Emerit I, Arutyunyan R, Oganesian N, et al. Radiation-induced clastogenic factors: anticlastogenic affect of Ginkgo biloba extract. Free Rad Biol & Med. 1995;18:985-991.
4. Rong Y, Geng Z, Lau BHS. Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells. Free Rad Biol & Med. 1996;20:121-127.
5. Baudouin C, Pisella PJ, Ettaiche M, et al. Effects of EGb 761 and superoxide dismutase in an experimental model of retinopathy generated by intravitreal production of superoxide anion radical. Graefes Arch Clin Exp Ophthalmol. 1999;237:58-66.
6. Tosaki A, Droy-Lefaix MT, Pali T, et al. Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat hearts. Free Rad Biol Med. 1993;14:361-370.
7. Pietri S, Maurelli E, Drieu K, et al. Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J Mol Cell Cardiol. 1997;29:733-742.
8. Haramaki N, Aggarwal S, Kawabata T, et al. Effects of natural antioxidant Ginkgo biloba extract (EGb 761) on myocardial ischemia-reperfusion injury. Free Rad Biol & Med. 1994;16:789-794.
9. Haines DD, Bak I, Ferdinandy P, et al. Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol. 2000;35:37-44.
10. Maitra I, Marcocci L, Droy-Lefaix MT, et al. Peroxyl radical scavenging activity of Ginkgo boliba extract EGb 761. Biochem Pharmacol. 1995;49: 1649-1655.
11. Shen J, Wang J, Zhao B, et al. Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrythmia in ischemia-reperfusion injury in vivo. Bioch Biophys Acta. 1998;1406:228-236.
12. Liebgott T, Miollan M, Berchadsky Y, et al. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Basic Res Cardiol. 2000;95:368-377.
13. Varga E, Bodi A, Ferdinandy P, et al. The protective effect of EGB 761 in isolated ischemic/reperfused rat hearts: a link between cardiac function and nitric oxide production. J Cardiovasc Pharmacol. 1999;34:711-717.
14. Meerson FZ, Belkina VE, Kozlov YP, et al. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol. 1982;77:465-485.
15. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 1987;84:1404-1407.
16. Barsacchi R, Coassin M, Maiorino M, et al. Increased ultra weak chemiluminescence emission from rat heart at postischemic reoxygenation: protective role of vitamin E. Free Rad Biol & Med. 1989;6:573-579.
17. Giannessi D, Lazzerini G, Sicari R, et al. Vasoactive eicosanoids in the rat heart: clues to a contributory role of cardiac thromboxane to postischaemic hyperaemia. Pharmacol Res. 1992;26:341-356.
18. Das DK, Maulik N, Moraru II. Gene expression in acute myocardial stress. Induction by hypoxia, ischemia, reperfusion, hyperthermia and oxidative stress. J Mol Cell Cardiol. 1995;28:181-193.
19. Kukielka GL, Smith CW, Manning AM, et al. Induction of interleukin-6 synthesis in the myocardium. Potential role in postperfusion inflammatory injury. Circulation. 1995;92:1866-1875.
20. Depre C, Fierain L, Hue L. Activation of nitric oxide synthase by ischemia in the perfusion heart. Cardiovasc Res. 1997;33:82-87.
21. Crofford IJ, Tan B, McCarthy CJ, et al. Involvement of nuclear factor κB in regulation of cycloxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum. 1997;40:226-236.
22. Schmedtje JF Jr, Ji YS, Liu WL, et al. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem. 1997;272:601-608.
23. D'Acquisto F, May MJ, Ghosh S. Inhibition of nuclear factor kappa B (NF-κB): an emerging theme in anti-inflammatory therapies. Mol Interv. 2002;2:22-35.
24. Schoonbroodt S, Piette J. Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochem Pharmacol. 2000;60:1075-1083.
25. Li C, Browder W, Kao RL. Early activation of transcription factor NF-κB during ischemia in perfused rat heart. Am J Physiol. [Heart Circ Physiol.] 1999;45:H543-H552.
26. Bakalova RA, Nekrasov AS, Lankin VZ, et al. A mechanism of the inhibitory effect of alpha-tocopherol and its synthetic analogs on the oxidation of linoleic acid catalyzed by lipoxygenase from reticulocytes. Proc Natl Acad Sci USSR. 1988;299:1008-1011.
27. Sakamoto W, Fujie K, Nishihira J, et al. Inhibition of PGE2 production in macrophages from vitamin E-treated rats. Prostaglandins Leukot Essent Fatty Acids. 1991;44:89-92.
28. Pentland AP, Morrison AR, Jacobs SC, et al. Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition. J Biol Chem. 1992;267:15578-15584.
29. Lang JK, Gohill R, Packer L. Simultaneous determination of tocopherols, ubiquinols and ubiquinones in blood, plasma, tissues and subcellular fractions. Anal Biochem. 1986;157:106-116.
30. + exchange occurring during hypoxia in the genesis of reoxigenation-induced myocardial oedema. J Mol Cell Cardiol. 1997;29:1167-1175.
31. Deryckere F, Gannon A. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques. 1994;16:405.
32. Inserte J, Garcia-Dorado D, Agulló L, et al. Urodilatin limits acute reperfusion injury in the isolated heart. Cardiovasc Res. 2000;45:351-359.
33. Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994;269:13057-13060.
34. Hemler ME, Lands WEM. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem. 1980;255:6253-6261.
35. Smith WL, Eling TE, Kulmacz RJ, et al. Tyrosyl radicals and their role in hydroperoxide-dependent activation and inactivation of prostaglandin endoperoxide synthase. Biochem J. 1992;31:3-7.
36. Kulmacz RJ, Wang LH. Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J Biol Chem. 1995;270:24019-24023.
37. Ricciarelli R, Tasinato A, Clément S, et al. α-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J. 1998;334:243-249.
38. Devaraj S, Jialal I. α-Tocopherol decreases interleukin-1β release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler Thromb Vasc Biol. 1999;19:1125-1133.
39. Wu D, Mura C, Beharka AA, et al. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Physiol. 1998;275:C661-C668.
40. Chandra V, Jasti J, Kaur P, et al. First structural evidence of a specific inhibition of phospholipase A2 by α-tocopherol (Vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and α-tocopherol at 1.8 A resolution. J Mol Biol. 2002;320:215-222.